Roche’s alzheimer’s drug clears plaques in 28 weeks, faces 2028 test to slow memory loss - Businessday NG

Roche’s experimental Alzheimer’s drug, trontinemab, has cleared harmful protein deposits from the brains of nine out of 10 patients within

Raccontata dabusinessday.ng